[go: up one dir, main page]

ATE425988T1 - Peptide mit affinitat fur ein phospholipid und deren verwendung - Google Patents

Peptide mit affinitat fur ein phospholipid und deren verwendung

Info

Publication number
ATE425988T1
ATE425988T1 AT03761668T AT03761668T ATE425988T1 AT E425988 T1 ATE425988 T1 AT E425988T1 AT 03761668 T AT03761668 T AT 03761668T AT 03761668 T AT03761668 T AT 03761668T AT E425988 T1 ATE425988 T1 AT E425988T1
Authority
AT
Austria
Prior art keywords
amino acids
gly
chosen
arg
independently
Prior art date
Application number
AT03761668T
Other languages
English (en)
Inventor
Alain Sanson
Francoise Ochsenbein
Original Assignee
Commissariat Energie Atomique
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Univ Paris Curie filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of ATE425988T1 publication Critical patent/ATE425988T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721Lipocortins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03761668T 2002-07-01 2003-06-30 Peptide mit affinitat fur ein phospholipid und deren verwendung ATE425988T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0208202A FR2841557B1 (fr) 2002-07-01 2002-07-01 Peptides ayant une affinite pour un phospholipide et utilisations

Publications (1)

Publication Number Publication Date
ATE425988T1 true ATE425988T1 (de) 2009-04-15

Family

ID=29725043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03761668T ATE425988T1 (de) 2002-07-01 2003-06-30 Peptide mit affinitat fur ein phospholipid und deren verwendung

Country Status (9)

Country Link
US (1) US7851440B2 (de)
EP (1) EP1517918B9 (de)
JP (1) JP4571493B2 (de)
AT (1) ATE425988T1 (de)
AU (1) AU2003259309A1 (de)
CA (1) CA2491343A1 (de)
DE (1) DE60326726D1 (de)
FR (1) FR2841557B1 (de)
WO (1) WO2004003015A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856070A1 (fr) * 2003-06-13 2004-12-17 Bionexis Molecules pour le ciblage et l'assemblage in situ de proteines therapeutiques et leur utilisation
CA2650008C (en) * 2006-04-25 2016-06-07 Centre National De La Recherche Scientifique (Cnrs) Functionalization of metal nanoparticles with oriented proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
WO1992019279A1 (en) * 1991-05-09 1992-11-12 Board Of Regents Of The University Of Washington Phospholipid-targeted thrombolytic agents
WO2000010673A1 (en) * 1998-08-24 2000-03-02 Nst Neurosurvival Technologies Ltd. Apparatus and method for capturing particles with surface exposure of anionic phospholipids from biological fluids
FR2784106B1 (fr) * 1998-10-02 2002-04-19 Commissariat Energie Atomique Structure chimique ayant une affinite pour un phospholipide, et compose de marquage, trousse de diagnostic, et medicament comprenant cette structure
US20030064072A9 (en) * 1999-03-12 2003-04-03 Rosen Craig A. Nucleic acids, proteins and antibodies

Also Published As

Publication number Publication date
FR2841557A1 (fr) 2004-01-02
US7851440B2 (en) 2010-12-14
AU2003259309A8 (en) 2004-01-19
JP2006514605A (ja) 2006-05-11
JP4571493B2 (ja) 2010-10-27
EP1517918A2 (de) 2005-03-30
EP1517918B9 (de) 2009-09-09
FR2841557B1 (fr) 2005-12-09
DE60326726D1 (de) 2009-04-30
AU2003259309A1 (en) 2004-01-19
WO2004003015A2 (fr) 2004-01-08
WO2004003015A3 (fr) 2004-04-08
CA2491343A1 (fr) 2004-01-08
US20060148689A1 (en) 2006-07-06
EP1517918B1 (de) 2009-03-18

Similar Documents

Publication Publication Date Title
Patthy Homology of the precursor of pulmonary surfactant-associated protein SP-B with prosaposin and sulfated glycoprotein 1.
DK0670898T3 (da) Interleukin-3 (IL-3)-mutantpolypeptider
Ansari et al. Complete amino acid sequence of a Lolium perenne (perennial rye grass) pollen allergen, Lol p II
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
EP0333356A3 (de) Hirudin-Peptide
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
DE60326581D1 (de) Markierte peptide mit einer affinität für ein phospholipid und deren verwendungen
Ohkura et al. Isolation and characterization of a phospholipase A2 inhibitor from the blood plasma of the Thailand cobra Naja naja kaouthia
ATE425988T1 (de) Peptide mit affinitat fur ein phospholipid und deren verwendung
HUP9702500A2 (hu) Elhízás elleni proteinek
Martin et al. Sequence homologies between p36, the substrate of pp60src tyrosine kinase and a 67 kDa protein isolated from bovine aorta
Hatakeyama et al. Amino acid sequences of the ribosomal proteins HL30 and HmaL5 from the archaebacterium Halobacterium marismortui
Seyer et al. Covalent structure of collagen: Amino acid sequence of three cyanogen bromide-derived peptides from human α1 (V) collagen chain
CO4340568A1 (es) Familia de peptidos con 51 aminoacidos en longitud, secuen- cias de definicion, la planta transgenica comprendida, el vector de expresion recombinante y el metodo para su pro- duccion.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties